Video

Investigational Treatment Shows Potential to Supress Memory Loss

Author(s):

Aaron H. Burstein, PharmD

Aaron Burstein, PharmD, shares details from a scientific presentation at the Alzheimer's Association International Conference.

MENTAL HEALTH MINUTE

Aaron Burstein, PharmD, senior vice president of vTv Therapeutics, shares the history and current status of development of azeliragon for the treatment of dementia and diabetes, including results recently presented at the 2020 Alzheimer's Association International Conference.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content
dementia
October 23rd 2024

Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of Dementia

Anil K. Bachu, MD Rashmi Phadke Subhedar, MD Maliha I. Ansari, MD Senthil Rajaram Manoharan, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
What Will the Future of Alzheimer Disease Treatment Look Like?
July 23rd 2021

What Will the Future of Alzheimer Disease Treatment Look Like?

Helen Lavretsky, MD, MS
aging brain
October 1st 2024

Traumatic Brain Injury’s Impact on Normal Aging and Neurodegenerative Diseases

Grace S. Griesbach, PhD
A Conversation With Drew Ramsey, MD, on Nutrition and Mental Health
March 9th 2021

A Conversation With Drew Ramsey, MD, on Nutrition and Mental Health

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
dementia
July 18th 2024

Treatment Options for the Management of Behavioral and Psychological Symptoms of Dementia

Anil K. Bachu, MD Rashmi Phadke Subhedar, MD Maliha I. Ansari, MD Senthil Rajaram Manoharan, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
FDA approval
July 2nd 2024

Alzheimer Disease Treatment Donanemab Receives FDA Approval

Leah Kuntz
© 2024 MJH Life Sciences

All rights reserved.